Vaccines
2 April 2014
Update on GSK’S MAGE-A3 Cancer Immunotherapeutic Phase 3 Study in Non-Small Cell Lung Cancer1 April 2014
Immunovaccine and Pfenex Report Positive Results from Single Dose Anthrax Vaccine Studies25 March 2014
Cellular Biomedicine Group Releases Positive Results From Phase I Clinical Trial for Hepatocellular Carcinoma25 March 2014
Valneva Announces the First Ever Marketing Authorization for a Human Vaccine Produced in the EB66® Cell Line24 March 2014
CAP-CMV GmbH Raises New Funds to Further Develop Its Novel hCMV Vaccine and Appoints New CEO24 March 2014
Valneva Announces Continuation of the Phase II/III Clinical Trial for its Pseudomonas Aeruginosa Vaccine Candidate21 March 2014
Ascend Biopharmaceutical’s ASN-002 demonstrates favourable response in a Phase 2 study in Cutaneous B-Cell Lymphoma19 March 2014
Sanofi Pasteur allies with SK Chemical Co. of South Korea on pneumococcal conjugate vaccine19 March 2014
VaxInnate Begins Phase I Clinical Trial to Evaluate Quadrivalent Vaccine for Prevention of Seasonal Flu11 March 2014
Novel Vaccine Trial Design Aims to Answer Key Tuberculosis Questions and Enhance Vaccine Development Strategy3 March 2014
TapImmune Releases Positive Interim Data on Phase I Clinical Trial in HER2/neu+ Breast Cancer27 February 2014
Allergen Research Corporation Initiates Phase 2b Clinical Trial for Peanut Allergy Oral Immunotherapy (OIT)News Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports